121-60-8 | N-Acetylsulfanilyl chloride

Packsize	Purity	Availability	Price	Discounted Price
5g	95%	in stock	$25.00	$17.00
25g	95%	in stock	$25.00	$18.00
100g	95%	in stock	$73.00	$51.00
500g	95%	in stock	$249.00	$175.00

Description

• Catalog Number: AB76966
• Chemical Name: N-Acetylsulfanilyl chloride
• CAS Number: 121-60-8
• Molecular Formula: C8H8ClNO3S
• Molecular Weight: 233.67202000000006
• MDL Number: MFCD00007442
• SMILES: CC(=O)Nc1ccc(cc1)S(=O)(=O)Cl
• NSC Number: 127860

Computed Properties

• Complexity: 301
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 14
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 2
• XLogP3: 1.4

Upstream Synthesis Route

$Name$ is a versatile compound commonly used in chemical synthesis for its reactivity and functionality. In particular, 4-Acetamidobenzene-1-sulfonyl chloride serves as a valuable reagent in the creation of various pharmaceuticals, agrochemicals, and advanced materials. Its sulfonyl chloride group can selectively react with nucleophiles to introduce the sulfonyl functionality into target molecules, enabling the formation of sulfonamides, sulfonylureas, and other sulfonylated compounds. This reagent is known for its robustness and efficiency in chemical transformations, making it a preferred choice in organic synthesis for the modification and derivatization of complex molecules.

Literature

• Synthesis of hapten and production of a monoclonal antibody against a derivative of L-hydroxyproline, a special amino acid in hydrolyzed animal protein.

  Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes 20130101

• 2-{4-[Acet-yl(eth-yl)amino]-benzene-sulfonamido}-benzoic acid.

  Acta crystallographica. Section E, Structure reports online 20120501

• N-[4-(Propyl-sulfamo-yl)phen-yl]acetamide.

  Acta crystallographica. Section E, Structure reports online 20120201

• N-[4-(Ethyl-sulfamo-yl)phen-yl]acetamide.

  Acta crystallographica. Section E, Structure reports online 20110901

• 2-(4-Acetamido-benzene-sulfonamido)-benzoic acid.

  Acta crystallographica. Section E, Structure reports online 20110701

• N-{4-[(2-Meth-oxy-phen-yl)sulfamo-yl]phen-yl}acetamide.

  Acta crystallographica. Section E, Structure reports online 20110201

• 3-[4-(Acetamido)-benzene-sulfonamido]-benzoic acid.

  Acta crystallographica. Section E, Structure reports online 20110101

• N-{4-[(4-Methyl-phen-yl)sulfamo-yl]phen-yl}acetamide.

  Acta crystallographica. Section E, Structure reports online 20100801

• N-[4-(Benzyl-sulfamo-yl)phen-yl]acetamide.

  Acta crystallographica. Section E, Structure reports online 20100801

• N-{4-[(3,4-Dimethyl-phen-yl)sulfamo-yl]phen-yl}acetamide.

  Acta crystallographica. Section E, Structure reports online 20100801

• 2-(4-Acetamido-benzene-sulfonamido)-3-methyl-butanoic acid.

  Acta crystallographica. Section E, Structure reports online 20100601

• Synthesis and antifungal properties of sulfanilamide derivatives of chitosan.

  Carbohydrate research 20071126

• The preparation and antioxidant activity of the sulfanilamide derivatives of chitosan and chitosan sulfates.

  Bioorganic & medicinal chemistry 20070601

• Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.

  Bioorganic & medicinal chemistry letters 20050502

• Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa.

  BMC cancer 20050101

• A novel kind of antitumour drugs using sulfonamide as parent compound.

  European journal of medicinal chemistry 20010101